Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume 30, Issue 23, Pages 2838-2844
Publisher
Oxford University Press (OUP)
Online
2009-11-01
DOI
10.1093/eurheartj/ehp477
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunological and Inflammatory Functions of the Interleukin-1 Family
- (2009) Charles A. Dinarello Annual Review of Immunology
- Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-κB Ligand and Risk for Coronary Events
- (2009) Anne G. Semb et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Osteoprotegerin Promotes Fibrous Cap Formation in Atherosclerotic Lesions of ApoE-Deficient Mice—Brief Report
- (2009) Olga Ovchinnikova et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: A prospective cohort study in ankylosing spondylitis
- (2009) I. C. van Eijk et al. ARTHRITIS AND RHEUMATISM
- Lymphotoxin β receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of agedApoE−/−mice
- (2009) Rolf Gräbner et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
- (2009) PAUL M. RIDKER JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
- (2009) Paul M Ridker et al. LANCET
- Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction
- (2009) Paola Secchiero et al. PLoS One
- Vaccination against atherosclerosis? Induction of atheroprotective immunity
- (2009) Göran K. Hansson et al. Seminars in Immunopathology
- Cytokine network and T cell immunity in atherosclerosis
- (2009) Hafid Ait-Oufella et al. Seminars in Immunopathology
- Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
- (2008) Joachim Listing et al. ARTHRITIS AND RHEUMATISM
- Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, Inhibits Apoptosis in Experimental Acute Myocardial Infarction
- (2008) Antonio Abbate et al. CIRCULATION
- CD137 Is Expressed in Human Atherosclerosis and Promotes Development of Plaque Inflammation in Hypercholesterolemic Mice
- (2008) Peder S. Olofsson et al. CIRCULATION
- Circulating Osteoprotegerin Levels and Long-Term Prognosis in Patients With Acute Coronary Syndromes
- (2008) Torbjørn Omland et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
- (2008) Josef S Smolen et al. LANCET
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study)
- (2008) David C Crossman et al. Trials
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More